Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The erythropoietin receptor expressed in skeletal muscle is essential for mitochondrial biogenesis and physiological exercise.
Nijholt KT, Meems LMG, Ruifrok WPT, Maass AH, Yurista SR, Pavez-Giani MG, Mahmoud B, Wolters AHG, van Veldhuisen DJ, van Gilst WH, Silljé HHW, de Boer RA, Westenbrink BD. Nijholt KT, et al. Among authors: yurista sr. Pflugers Arch. 2021 Aug;473(8):1301-1313. doi: 10.1007/s00424-021-02577-4. Epub 2021 Jun 17. Pflugers Arch. 2021. PMID: 34142210 Free PMC article.
Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction.
Yurista SR, Silljé HHW, Oberdorf-Maass SU, Schouten EM, Pavez Giani MG, Hillebrands JL, van Goor H, van Veldhuisen DJ, de Boer RA, Westenbrink BD. Yurista SR, et al. Eur J Heart Fail. 2019 Jul;21(7):862-873. doi: 10.1002/ejhf.1473. Epub 2019 Apr 29. Eur J Heart Fail. 2019. PMID: 31033127 Free article.
ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca2+ Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ.
Pavez-Giani MG, Sánchez-Aguilera PI, Bomer N, Miyamoto S, Booij HG, Giraldo P, Oberdorf-Maass SU, Nijholt KT, Yurista SR, Milting H, van der Meer P, Boer RA, Heller Brown J, Sillje HWH, Westenbrink BD. Pavez-Giani MG, et al. Among authors: yurista sr. Int J Mol Sci. 2021 Apr 23;22(9):4427. doi: 10.3390/ijms22094427. Int J Mol Sci. 2021. PMID: 33922643 Free PMC article.
Effects of Sodium-Glucose Co-transporter 2 Inhibition with Empaglifozin on Renal Structure and Function in Non-diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction.
Yurista SR, Silljé HHW, van Goor H, Hillebrands JL, Heerspink HJL, de Menezes Montenegro L, Oberdorf-Maass SU, de Boer RA, Westenbrink BD. Yurista SR, et al. Cardiovasc Drugs Ther. 2020 Jun;34(3):311-321. doi: 10.1007/s10557-020-06954-6. Cardiovasc Drugs Ther. 2020. PMID: 32185580 Free PMC article.
SGLT2 Inhibitors and Ketone Metabolism in Heart Failure.
Saucedo-Orozco H, Voorrips SN, Yurista SR, de Boer RA, Westenbrink BD. Saucedo-Orozco H, et al. Among authors: yurista sr. J Lipid Atheroscler. 2022 Jan;11(1):1-19. doi: 10.12997/jla.2022.11.1.1. Epub 2022 Jan 13. J Lipid Atheroscler. 2022. PMID: 35118019 Free PMC article.
Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure.
Yurista SR, Matsuura TR, Silljé HHW, Nijholt KT, McDaid KS, Shewale SV, Leone TC, Newman JC, Verdin E, van Veldhuisen DJ, de Boer RA, Kelly DP, Westenbrink BD. Yurista SR, et al. Circ Heart Fail. 2021 Jan;14(1):e007684. doi: 10.1161/CIRCHEARTFAILURE.120.007684. Epub 2020 Dec 28. Circ Heart Fail. 2021. PMID: 33356362 Free PMC article.
21 results